Insider trade

Agomab Therapeutics (AGMB): Director bought ~$45K

David R Epstein, Director at Agomab Therapeutics, bought ~$45K of Agomab Therapeutics shares.

~$45K
Approx. value · 5,000 sh @ $8.90: 25K
Holds after · shares reported

Traded: Oct 21, 2026
Filed: Oct 22, 2026

Context

Written by software from the filings listed below · Oct 23, 2026

What was filed. David R Epstein, Director, reported an open-market purchase of 5,000 Agomab Therapeutics (AGMB) shares at $8.90 each, about $45K. SEC Form 4

4 more points, with the facts they come from, are in OQRO Pro.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 5, 2026Insider · 2 peopleInsiders: 2 purchases (~$94K)
Oct 6, 2026Insider · 3 peopleInsiders: 5 purchases (~$173K)
Oct 8, 2026InsiderDirector purchased ~$45K of AGMB shares in the open market
Oct 21, 2026 · this disclosureInsiderDirector purchased ~$45K of AGMB shares in the open market

What came next

Oct 21, 2026InsiderDirector purchased ~$44K of AGMB shares in the open market
Nov 5, 2026Insider · 1 personInsiders: 3 purchases (~$104K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Agomab Therapeutics

For Agomab Therapeutics, OQRO holds 13 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AGMB page.

Other recent filings by David R Epstein, Director

The full history of David R Epstein, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Agomab Therapeutics

Everything OQRO holds on this company is on its AGMB page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data